Published in Dig Dis Sci on August 01, 1998
Safety of the long-term use of proton pump inhibitors. World J Gastroenterol (2010) 1.55
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc (1991) 31.17
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology (1998) 5.02
Risk of adverse birth outcomes in populations living near landfill sites. BMJ (2001) 4.96
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem (1987) 3.71
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Assessing the significance of the correlation between two spatial processes. Biometrics (1989) 2.63
Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia (2007) 2.60
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med (1997) 2.56
A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group. N Engl J Med (1998) 2.54
Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology (1995) 2.47
Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem (1996) 2.33
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
A time series construction of an alert threshold with application to S. bovismorbificans in France. Stat Med (1991) 2.19
Fatal colonic explosion during colonoscopic polypectomy. Gastroenterology (1979) 2.12
Accounting for pregnancy dependence in epidemiologic studies of reproductive outcomes. Epidemiology (1997) 2.07
Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol (1998) 2.03
The Newcastle Control Score: a new method of grading the severity of intermittent distance exotropia. Br J Ophthalmol (2004) 2.02
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet (1993) 2.00
Geographic density of landfill sites and risk of congenital anomalies in England. Occup Environ Med (2008) 2.00
Comparison of relative risks obtained in ecological and individual studies: some methodological considerations. Int J Epidemiol (1987) 1.97
Variable selection and Bayesian model averaging in case-control studies. Stat Med (2001) 1.91
Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology (2004) 1.91
Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol (1996) 1.89
Etiology of acute childhood encephalitis at The Hospital for Sick Children, Toronto, 1994-1995. Clin Infect Dis (1998) 1.85
Incidence of inflammatory bowel disease in northern France (1988-1990). Gut (1994) 1.81
Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology (1996) 1.73
Acute childhood encephalitis and Mycoplasma pneumoniae. Clin Infect Dis (2001) 1.72
Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease. J Hematother (1995) 1.71
Utilization of paraffin-embedded material for electron microscopy. Study of an A2-cell type microadenoma of the endocrine pancreas. Lab Invest (1970) 1.70
Clinical characteristics of Crohn's disease in 72 families. Gastroenterology (1996) 1.70
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther (2011) 1.69
Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol (2000) 1.69
Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology (1997) 1.69
Distal femoral osteotomy for lateral compartment osteoarthritis of the knee. Orthopedics (1998) 1.68
Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology (1999) 1.68
Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study. Dis Colon Rectum (1991) 1.65
Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut (2005) 1.65
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Short-term effects of sulphur dioxide pollution on mortality in two French cities. Int J Epidemiol (1989) 1.64
Latent pulmonary involvement in Crohn's disease: biological, functional, bronchoalveolar lavage and scintigraphic studies. Gut (1986) 1.63
Genetically related Escherichia coli strains associated with Crohn's disease. Gut (2001) 1.61
Inflammatory bowel disease in married couples: 10 cases in Nord Pas de Calais region of France and Liège county of Belgium. Gut (1994) 1.57
Easy clip to treat anal fistula tracts: a word of caution. Int J Colorectal Dis (2015) 1.55
Perioperative endoscopy of the whole small bowel in Crohn's disease. Gut (1993) 1.54
Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum. Br J Clin Pharmacol (1985) 1.48
Frisby Davis distance stereoacuity values in visually normal children. Br J Ophthalmol (2005) 1.47
Changes in Helicobacter pylori ultrastructure and antigens during conversion from the bacillary to the coccoid form. Infect Immun (1996) 1.47
Statistical issues in the analysis of disease mapping data. Stat Med (2001) 1.46
Postoperative management of stage II/III colon cancer: a decision analysis. Gastroenterology (1999) 1.45
Evidence of gastritis with several Helicobacter pylori strains. Lancet (1989) 1.43
Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology (2007) 1.43
Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component. Lancet (1991) 1.42
Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward. Pediatr Infect Dis J (1999) 1.41
Use of antenatal steroids to counteract the negative effects of tracheal occlusion in the fetal lamb model. Pediatr Res (2001) 1.41
[Infliximab therapy for Crohn's disease anoperineal lesions]. Gastroenterol Clin Biol (2001) 1.40
Nurse sounds warning about Christchurch health changes. Nurs N Z (2001) 1.40
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression. Aliment Pharmacol Ther (2008) 1.40
[Adult asthma exacerbations in questions]. Rev Mal Respir (2010) 1.40
[Evaluation of a new sequence of magnetic resonance cholangio-pancreatography in thick cut and one shot acquisition]. Gastroenterol Clin Biol (2000) 1.40
Multilocus genotypes and DNA fingerprints Do not predict variation in azole resistance among clinical isolates of Candida albicans. Antimicrob Agents Chemother (1999) 1.40
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1992) 1.39
[Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease]. Rev Epidemiol Sante Publique (1999) 1.39
A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. Kidney Int (2007) 1.38
Diagnosis of lipid malabsorption in patients with chronic pancreatitis: a new indirect test using postprandial plasma apolipoprotein B-48. Am J Gastroenterol (1999) 1.38
Experimental infection of gnotobiotic mice with Campylobacter jejuni: colonisation of intestine and spread to lymphoid and reticulo-endothelial organs. J Med Microbiol (1985) 1.35
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34
Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci (1997) 1.33
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut (1997) 1.31
Growth-physiological changes in Escherichia coli and other bacteria during division inhibition by 5-diazouracil. J Bacteriol (1969) 1.30
Survey of family physicians: what is their role in cancer patient care? Can J Oncol (1994) 1.30
Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys (1997) 1.30
Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis (1992) 1.30
Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin Exp Immunol (1988) 1.29
Palliative treatment of rectosigmoid carcinoma by laser endoscopic photoablation. Gastroenterology (1987) 1.27
Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology (1986) 1.27
Antibiotics in Crohn's disease. Gut (2001) 1.25
Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. J Biol Chem (1997) 1.24
Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients. Am J Gastroenterol (2001) 1.24
Screening for correctable visual acuity deficits in school-age children and adolescents. Cochrane Database Syst Rev (2005) 1.23
Isolation and characterization of two Campylobacter glycine-extracted proteins that bind to HeLa cell membranes. Infect Immun (1993) 1.22
HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France. Int J Epidemiol (1993) 1.22
Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer (1994) 1.22
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut (2004) 1.20
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut (2003) 1.19
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther (2010) 1.18
Panmictic structure of Helicobacter pylori demonstrated by the comparative study of six genetic markers. FEMS Microbiol Lett (1998) 1.18
Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J (1993) 1.17
Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. The IOIBD Budesonide Study Group. Gastroenterology (1999) 1.17
Biases in ecological studies: utility of including within-area distribution of confounders. Stat Med (2000) 1.16
Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg (1989) 1.16
Ecological analysis of digestive cancer mortality related to contamination by diarrhetic shellfish poisoning toxins along the coasts of France. Environ Res (2000) 1.13